Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 425 of 5804
-
Less water, better lungs? new trial aims to protect preemies
Prevention Recruiting nowThe aim of this study is to determine whether restricted fluid intake (135 ±5 mL/kg/day) compared to liberal fluid intake (165 ±5 mL/kg/day) from day 8 of life reduces the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age or prior death in preterm infant…
Phase: NA • Sponsor: University Children's Hospital Basel • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
New yellow fever vaccine trial for kids could boost global protection
⭐️ VACCINE ⭐️ Recruiting nowThe purpose of this study is to determine whether vYF (investigational vaccine) is safe and can help the body to develop antibodies (immunogenicity) compared with Stamaril vaccine and YF-VAX vaccine (both licensed vaccines) and when they are co-administered with Measles Mumps Rub…
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Can early plasma exchange save sight and mobility?
Disease control Recruiting nowThe purpose of this research is to evaluate if early vs rescue Therapeutic Plasma Exchange (PLEX) treatment algorithm leads to better visual outcomes in severe Optic Neuritis and leads to better neurological disability outcomes in severe Transverse Myelitis.
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Engineered immune cells take on lupus in early trial
Disease control Recruiting nowA clinical study to explore the safety, efficacy and cell metabolic kinetics of universal CD19/20 car-t cell injection in moderate to severe refractory systemic lupus erythematosus. This study is a single arm, open, exploratory dose increasing clinical study, which aims to evalu…
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Timing is everything: new trial aims to reduce transplant complications by adjusting when stem cells are given
Disease control Recruiting nowTo observe the effect of stem cell infusion on the development of acute graft- versus-host disease (aGVHD) in patients with malignant hematologic diseases after single-unit unrelated cord blood transplantation (sUCBT).
Phase: PHASE3 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New brain scanner could spot bleeding in minutes without radiation
Diagnosis Recruiting nowThe study population will consist of 3 mutually-exclusive sets of patients and subjects: * TBI patients with intracranial bleeding * TBI patients without intracranial bleeding * Control subjects with normal brain health. Research subjects ages 22 and older will be enrolled. All…
Sponsor: Sense Diagnostics, LLC • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo shows promise for Tough-to-Treat anal cancer
Disease control Recruiting nowThe purpose of this study is to gather information on the safety and effectiveness of lenvatinib combined with pembrolizumab in anal/rectal cancer that has spread to other parts of the body and will not respond to standard care.
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a triple therapy stop strokes from coming back?
Disease control Recruiting nowCurrently, aspirin plus clopidogrel is considered as a standard acute treatment of ischemic stroke, based on results of CHANCE and POINT trial. However, still a considerable portion of patients showed early stroke recurrence, especially in those with stroke due to large artery at…
Phase: PHASE4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a drug combo ease Alzheimer's agitation? large trial underway
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Immunotherapy plus radiation aims to stop liver cancer recurrence
Disease control Recruiting nowThis study is an open-label, randomized controlled, multicenter, phase III clinical trial
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New device could keep donor hearts alive longer for transplant
Disease control Recruiting nowThe purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Nanovaccine trains immune cells to hunt lung cancer
Disease control OngoingTumor-reactive T cells are generated based on the tumor full antigen nanovaccine and the tumor-reactive T cells are reinjected for autologous therapy to provide the optimal treatment plan for clinical patients.
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Ketamine booster for shock therapy? new trial aims to lift depression and protect memory
Symptom relief Recruiting nowThis is a randomized, double-blind, placebo-controlled phase 3 clinical trial evaluating the additive effect of intravenous ketamine in combination with electroconvulsive therapy (ECT) in patients with treatment-resistant major depressive disorder (MDD). The study aims to determi…
Phase: PHASE3 • Sponsor: Università Vita-Salute San Raffaele • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Engineered immune cells offer new hope for Hard-to-Treat leukemia
Disease control Recruiting nowRefractory/Relapsed (R/R) acute myeloid leukemia (AML) is associated with a dis-mal prognosis. In some subsets of AML such as AML driven by the t(8;21) translocation, leading to the RUNX1-RUNX1T1 (AML1-ETO) fusion transcript expression, CD19 B-cell antigen is aberrantly expresse…
Phase: PHASE1 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug combo may help save kidneys in High-Risk cancer patients
Disease control Recruiting nowThrough the neoadjuvant treatment with a combination of Pucotenlimab and Vorolanib, it enabled the successful and safe implementation of partial nephrectomy in patients with localized renal cancer, who had indications for nephron-sparing surgery but faced considerable difficulty …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New CAR-T therapy aims to tackle tough lymphoma
Disease control Recruiting nowA Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma.
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
BREAST CANCER BREAKTHROUGH? new study lets patients choose chemo-free treatment
Disease control Recruiting nowThis is a Phase II, two-arm, single center, patient preference study designed to evaluate the impact of omitting adjuvant chemotherapy in moderate to high-anatomical risk, low-genomic risk (men or premenopausal women T2-3N0 and RS 16-25, or T1-3N1-2 and RS ≤ 25, and postmenopausa…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Sound waves aimed at the brain could quiet seizures
Disease control Recruiting nowThe goal of this study is to investigate the effects of a non-invasive, low intensity focused ultrasound (LIFU) stimulation on seizure frequency and the epileptogenic network in drug-resistant epilepsy. LIFU uses focused sound waves to modulate deep brain regions and to enable ch…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo aims to boost immune attack on Hard-to-Treat prostate cancer
Disease control Recruiting nowA single-center phase Ib/II dose escalation and dose-expansion clinical trial of REGN5678 plus cemiplimab
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Head-to-Head: which migraine pill works best?
Disease control Recruiting nowThis goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC